Valuable predictive features of relapse of Graves' disease after antithyroid drug treatment.

@article{Liu2015ValuablePF,
  title={Valuable predictive features of relapse of Graves' disease after antithyroid drug treatment.},
  author={Xingjun Liu and Bingyin Shi and Hao Li},
  journal={Annales d'endocrinologie},
  year={2015},
  volume={76 6},
  pages={679-83}
}
PURPOSE Antithyroid drug treatment (ATDT) effectively achieves euthyroidism in patients with Graves' disease (GD). However, apparently successful treatment may be followed by relapse. We investigated the outcome of ATDT in Chinese patients with GD to identify predictive features of relapse. METHODS In total, 133 patients with mild to moderate goiter were included in this analysis. All patients received methimazole for 12 to 40 months and were subsequently followed up for at least 1 year… CONTINUE READING